Paper Details

  1. Home
  2. Paper Details

Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials.

Author: OrologioIlaria, RussoAntonio, SicilianoMattia, SilvestroMarcello, TedeschiGioacchino, TessitoreAlessandro, TrojsiFrancesca

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review examines the evolution of migraine prevention strategies, focusing on the recent advent of monoclonal antibodies against Calcitonin Gene-Related Peptide (CGRP) and gepants. These new agents offer significant advantages in terms of efficacy, safety, and tolerability compared to older preventative medications. However, their high cost may limit their use to more severe migraine phenotypes.
Paper Details　
Original Abstract of the Article :
Migraine is a leading cause of years lived with disability and preventive strategies represent a mainstay to reduce health-related disability and improve quality of life of migraine patients. Until a few years ago, migraine prevention was based on drugs developed for other clinical indications and r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14728214.2023.2207819

データ提供：米国国立医学図書館（NLM）

Migraine: A Desert of Pain, A New Oasis of Hope

Migraine, like a relentless desert wind, can cause debilitating pain and affect quality of life. This research reviews emerging drugs for the preventive treatment of migraine, specifically focusing on CGRP monoclonal antibodies and gepants, a new class of CGRP receptor antagonists. The researchers, like skilled desert explorers, seek to identify new and effective treatments to combat the challenges of migraine.

A New Dawn in Migraine Treatment

The research, like a refreshing oasis in the desert of migraine, highlights the potential of CGRP monoclonal antibodies and gepants. The findings, like a map guiding us through the desert of treatment options, reveal the effectiveness and tolerability of these new therapies, offering a glimmer of hope for patients suffering from migraine. This research, like a beacon in the desert of pain, provides valuable insights into the future of migraine prevention.

Navigating the Desert of Migraine

This research emphasizes the importance of preventive strategies for managing migraine and improving quality of life for patients. The findings, like a cool breeze in the desert, offer a reminder that new and effective treatment options are emerging, providing hope for a brighter future for individuals battling migraine. This research, like a compass guiding us through the desert of migraine, underscores the importance of continued research and innovation to find better treatments for this debilitating condition.

Dr. Camel's Conclusion

This research explores the potential of CGRP monoclonal antibodies and gepants as new and effective preventive treatments for migraine. The findings highlight the effectiveness and tolerability of these therapies, offering hope for a brighter future for individuals battling migraine. This research, like a beacon in the desert of pain, provides valuable insights into the evolving landscape of migraine treatment and the importance of continued research and innovation to find better treatments for this debilitating condition.
Date :
  1. Date Completed 2023-06-29
  2. Date Revised 2023-06-30
Further Info :

Pubmed ID

37185047

DOI: Digital Object Identifier

10.1080/14728214.2023.2207819

Related Literature

Article Analysis
・Effects of rimegepant・Effects of atogepant
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.